WY
27
-7
AEE
46
11
CVX
23
-2
DG
32
-2
OI
26
-2
AMGN
47
-13
HSIC
44
4
CMA
39
3
CINF
48
-2
GM
61
-4
KR
50
10
GOOGL
67
3
VLO
33
-5
ADT
55
25
SLB
48
2
NOV
37
-2
AIV
60
3
MDLZ
36
4
LEG
20
-8
RRC
46
-2
WY
27
-7
AEE
46
11
CVX
23
-2
DG
32
-2
OI
26
-2
AMGN
47
-13
HSIC
44
4
CMA
39
3
CINF
48
-2
GM
61
-4
KR
50
10
GOOGL
67
3
VLO
33
-5
ADT
55
25
SLB
48
2
NOV
37
-2
AIV
60
3
MDLZ
36
4
LEG
20
-8
RRC
46
-2
Financhill
Back

Enphase Energy Vs. Ultragenyx Pharmaceutical Industry Stock Comparison

Sell
25

ENPH
Enphase Energy

Last Price:
106.68
Seasonality Move:
18.84%
Sell
43

RARE
Ultragenyx Pharmaceutical

Last Price:
39.58
Seasonality Move:
3.65%
Sell
25
Enphase Energy (ENPH) is a Sell

Is Enphase Energy a Buy, Sell or Hold?

  • The current Enphase Energy [ENPH] share price is $106.67. The Score for ENPH is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
  • ENPH is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
43
Ultragenyx Pharmaceutical (RARE) is a Sell

Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?

  • The current Ultragenyx Pharmaceutical [RARE] share price is $39.60. The Score for RARE is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
  • RARE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

ENPH Stock Price Chart

What is Enphase Energy's stock price today?

  • The Enphase Energy share price today is $106.67
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ENPH is experiencing slight selling pressure.

RARE Stock Price Chart

What is Ultragenyx Pharmaceutical's stock price today?

  • The Ultragenyx Pharmaceutical share price today is $39.60
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RARE is experiencing buying pressure, which is a positive indicator for future bullish movement.

ENPH Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.87 Sell
Relative Strength Index (14 RSI): 35.87 Sell
Chaikin Money Flow: -1469216 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (115.5 - 131.42) Sell
Bollinger Bands (100): (109.34 - 126.72) Sell

RARE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.73 Sell
Relative Strength Index (14 RSI): 45.77 Sell
Chaikin Money Flow: 722527 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (38.99 - 42.29) Sell
Bollinger Bands (100): (41.03 - 48.83) Sell

ENPH Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 122.04 Sell
20-day SMA: 125.45 Sell
50-day SMA: 117.6 Sell
200-day SMA: 114.01 Sell
8-day EMA: 118.29 Sell
20-day EMA: 121.7 Sell
50-day EMA: 119.91 Sell
200-day EMA: 125.74 Sell

RARE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 40.38 Sell
20-day SMA: 40.41 Sell
50-day SMA: 41.94 Sell
200-day SMA: 42.46 Sell
8-day EMA: 39.76 Sell
20-day EMA: 40.54 Sell
50-day EMA: 42.03 Sell
200-day EMA: 43.46 Sell

Enphase Energy Earnings Growth & ENPH Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.12 per share, an increase next quarter of $0.31 per share, a decrease this year of $1.50 per share, and an increase next year of $2.22 per share.

Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.49 per share, an increase next quarter of $0.01 per share, an increase this year of $0.90 per share, and an increase next year of $1.07 per share.

Enphase Energy Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Ultragenyx Pharmaceutical Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):